We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Elanco Animal Health (ELAN) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Wall Street analysts expect Elanco Animal Health Incorporated (ELAN - Free Report) to post quarterly earnings of $0.24 per share in its upcoming report, which indicates a year-over-year increase of 33.3%. Revenues are expected to be $1.15 billion, up 9.2% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Elanco Animal Health metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Revenue- Total Pet Health' will reach $593.58 million. The estimate suggests a change of +14.6% year over year.
The average prediction of analysts places 'Revenue- Total Contract Manufacturing' at $13.44 million. The estimate points to a change of +12% from the year-ago quarter.
Analysts forecast 'Revenue- Total Farm Animal' to reach $548.11 million. The estimate suggests a change of +4% year over year.
Over the past month, shares of Elanco Animal Health have returned -13.3% versus the Zacks S&P 500 composite's -2.9% change. Currently, ELAN carries a Zacks Rank #4 (Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Elanco Animal Health (ELAN) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Wall Street analysts expect Elanco Animal Health Incorporated (ELAN - Free Report) to post quarterly earnings of $0.24 per share in its upcoming report, which indicates a year-over-year increase of 33.3%. Revenues are expected to be $1.15 billion, up 9.2% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Elanco Animal Health metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Revenue- Total Pet Health' will reach $593.58 million. The estimate suggests a change of +14.6% year over year.
The average prediction of analysts places 'Revenue- Total Contract Manufacturing' at $13.44 million. The estimate points to a change of +12% from the year-ago quarter.
Analysts forecast 'Revenue- Total Farm Animal' to reach $548.11 million. The estimate suggests a change of +4% year over year.
View all Key Company Metrics for Elanco Animal Health here>>>
Over the past month, shares of Elanco Animal Health have returned -13.3% versus the Zacks S&P 500 composite's -2.9% change. Currently, ELAN carries a Zacks Rank #4 (Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>